Clinical Experience Depicting Wound Regression Trends with carePATCH: A Case Series
Summary: A case series by Nan E. Hodge, DPM, Corey B. Dahl, PA, Brian B. Liljenquist, DPM, and Eric J. Thomas, DPM, evaluated outcomes when carePATCH — a dehydrated, dual-layer amniotic membrane allograft (ExtremityCare LLC, US) — was added to standard of care (SoC) for hard-to-heal wounds unresponsive to SoC alone. Results demonstrated significant wound regression and positive clinical outcomes across multiple wound types.
Key Highlights:
- Study objective: Assess whether carePATCH improves outcomes in chronic wounds that failed to reduce ≥50% in surface area after 30 days of SoC treatment.
- Methods: Data from 13 patients (mean age: 75.1 years) between Nov 2023–Jan 2025 were analyzed. Wounds included venous leg ulcers (n=6), pressure ulcers (n=5), post-surgical wounds (n=1), and venous stasis/arterial wounds (n=1).
- Application: carePATCH was applied as an adjunct following wound debridement per best practice standards.
- Results: Median percentage area reduction (PAR) at final application was 77.4%, increasing to 100% at one week post-final application.
- Statistical significance: Improvement in PAR outcomes was significant (p=0.017 at final application; p=0.003 at one week post-application).
- Conclusion: carePATCH showed consistent wound regression trends across wound types, supporting its role as a promising adjunct to SoC in managing chronic, non-healing wounds.
Read the full case series in Journal of Wound Care
Keywords:
carePATCH,
amniotic membrane,
chronic wounds,
standard of care,
venous leg ulcer,
pressure ulcer